U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07256405) titled 'Metagenomic Next-Generation Sequencing for the Diagnosis of Fracture-related Infection' on Nov. 20.
Brief Summary: The value of next-generation sequencing (NGS) using Nanopore technology has been demonstrated in the case of diabetic patients' wounds or in prosthetic joint infections. The aim of this study is to demonstrate its relevance as a new diagnostic approach for fracture-related infections (FRI).
Bone samples from patient with FRI will be submitted to shotgun metagenomic Next-generation sequecing using Oxford Nanopore Technology (ONT) in order to establish its diagnostic value in this context in comparison with the reference ...